Latest Us Operations News

Change Financial has confirmed meeting its upgraded FY26 revenue and underlying EBITDA targets, powered by strong growth in its Australian and New Zealand PaaS business. The company enters FY27 with record monthly metrics but holds back on full-year guidance amid client migration uncertainties.

Resolution Minerals has completed 16 diamond core holes totalling 4,470 metres at its Golden Gate South prospect in Idaho, progressing one third of its 2026 drill program aimed at defining gold and tungsten mineralisation.

Smart Parking (ASX:SPZ) has acquired American Parking, adding 54 sites across Oklahoma, Texas, and Arkansas and boosting its US portfolio to over 200 locations. The $12 million deal is expected to be earnings accretive and supports the rollout of SmartCloud technology.

Resolution Minerals has completed a third of its 2026 drill program at Golden Gate South, Idaho, with 16 diamond core holes totaling 4,470 metres. The drilling aims to delineate extensions of gold and tungsten mineralisation near historical workings, supporting resource growth at the Horse Heaven project.

Aroa Biosurgery delivered a breakout FY26 with NZ$104 million revenue, driven by strong Myriad sales and clinical trial success, setting the stage for ambitious FY27 growth.

Iondrive Limited has gained a significant boost from the Oklahoma Department of Commerce, receiving a Letter of Support and potential incentives valued at over US$15 million for scaling its rare earth recycling modules in the US.

ArborGen Holdings reported a solid FY26 with record revenue driven by Brazil expansion and a 31% EBITDA increase, offsetting a challenging US market. Leadership changes and operational discipline mark the company’s path forward.

Resolution Minerals has secured membership in the US Defense Industrial Base Consortium, opening doors to funding and collaboration that could accelerate its critical minerals projects in Idaho.

Vitrafy Life Sciences has launched a non-underwritten Share Purchase Plan to raise approximately A$2 million, offering existing Australian and New Zealand shareholders the chance to buy shares at A$2.60 each, matching the recent institutional placement price.

Melbana Energy halts direct involvement in its Cuban Block 9 project following US sanctions on CUPET, its contractual counterparty, while it seeks legal clarity on the complex regulatory landscape.

Hydralyte USA secures A$392,000 through a share placement, appoints two new non-executive directors, and implements significant cost reductions following CEO resignation as it targets cash-flow break-even and strategic expansion.

Vitrafy Life Sciences has secured A$30 million through an institutional placement to ramp up manufacturing of its Guardion cryopreservation devices and expand US sales operations, with an additional A$2 million sought via a shareholder plan.